Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: role of an inducible cyclooxygenase metabolite.

Zerrouk, A

Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: role of an inducible cyclooxygenase metabolite. [electronic resource] - Journal of cardiovascular pharmacology Apr 1998 - 525-33 p. digital

Publication Type: Comparative Study; Journal Article

0160-2446

10.1097/00005344-199804000-00009 doi


Angiotensin II--antagonists & inhibitors
Animals
Aorta, Thoracic--drug effects
Aspirin--pharmacology
Bridged Bicyclo Compounds, Heterocyclic
Cycloheximide--pharmacology
Cyclooxygenase Inhibitors--pharmacology
Dactinomycin--pharmacology
Endothelium, Vascular--drug effects
Enzyme Induction--drug effects
Fatty Acids, Unsaturated
Hydrazines--pharmacology
In Vitro Techniques
Male
Muscle Contraction--drug effects
Nitrobenzenes--pharmacology
Piroxicam--pharmacology
Prostaglandin-Endoperoxide Synthases--biosynthesis
Prostaglandins--metabolism
Protein Synthesis Inhibitors--pharmacology
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Sulfonamides--pharmacology
Time Factors
Vasoconstrictor Agents--pharmacology